Rex Pharmaceuticals (India) Limited
About Rex Pharmaceuticals (India) Limited
Data last updated: 24 July 2025
Rex Pharmaceuticals (India) Limited is a public limited company based in Veraval, Gujarat, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It specialises in speciality chemicals, a part of the broader chemicals sector. Incorporated on 22 March 1990, the company has been in operation for over 36 years.
Registered with ROC Ahmedabad under CIN U24232GJ1990PLC013531.
Capital: an authorised share capital of ₹15 Lakh and a paid-up capital of ₹70.
Last AGM: 30 September 1999. Financial statements filed for year ended 31 March 1999. Office: Patan Darwaja Junagadh, Veraval, Gujarat, India.
The company is under the process of being struck off by the Registrar of Companies. This typically indicates non-filing of statutory returns, and the company may soon cease to exist as a legal entity.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressPatan Darwaja Junagadh, Veraval, Gujarat, India
-
IndustryChemicals, Other Chemical Product, Manufacturing
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Board of Directors of Rex Pharmaceuticals (India) Limited
The Directors information for Rex Pharmaceuticals (India) Limited provides insights into the leadership structure and governance of the organization.
Financials of Rex Pharmaceuticals (India) Limited
Ten-year financial statements for Rex Pharmaceuticals (India) Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings Rex Pharmaceuticals (India) Limited
Rex Pharmaceuticals (India) Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rex Pharmaceuticals (India) Limited
View historical data on people associated with Rex Pharmaceuticals (India) Limited, including employment history and EPFO contributions.
Employee and EPFO history for Rex Pharmaceuticals (India) Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Rex Pharmaceuticals (India) Limited
GST registrations and filing compliance for Rex Pharmaceuticals (India) Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Rex Pharmaceuticals (India) Limited
Credit ratings, litigation, and regulatory alerts for Rex Pharmaceuticals (India) Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rex Pharmaceuticals (India) Limited
MSME payment history for Rex Pharmaceuticals (India) Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rex Pharmaceuticals (India) Limited
Corporate group structure for Rex Pharmaceuticals (India) Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rex Pharmaceuticals (India) Limited
MCA filings and documents for Rex Pharmaceuticals (India) Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Rex Pharmaceuticals (India) Limited
Frequently Asked Questions about Rex Pharmaceuticals (India) Limited
Rex Pharmaceuticals (India) Limited is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Rex Pharmaceuticals (India) Limited is a company pending strike off, currently registered as a public limited company in the chemicals sector based in Veraval, Gujarat, India. It was incorporated on 22 March 1990 and is registered under CIN U24232GJ1990PLC013531. The company may be struck off soon - caution is advised.
The CIN (Corporate Identification Number) of Rex Pharmaceuticals (India) Limited is U24232GJ1990PLC013531. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Rex Pharmaceuticals (India) Limited is chemicals. The company specifically operates in other chemical product.
Rex Pharmaceuticals (India) Limited can be reached at the registered office: Patan Darwaja Junagadh, Veraval, Gujarat, India.
The authorised capital is ₹15 Lakh, and the paid-up capital is ₹70.